Clearside Biomedical (CLSD)
(Delayed Data from NSDQ)
$1.45 USD
+0.12 (9.02%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.43 -0.02 (-1.38%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Earnings News For CLSD
-
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Q4 Earnings and Revenues Beat Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Misses Revenue Estimates
-
Analysts Estimate Clearside Biomedical, Inc. (CLSD) to Report a Decline in Earnings: What to Look Out for
-
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Tops Revenue Estimates
-
Will Clearside Biomedical, Inc. (CLSD) Report Negative Earnings Next Week? What You Should Know
-
Analysts Estimate Clearside Biomedical, Inc. (CLSD) to Report a Decline in Earnings: What to Look Out for
-
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Lags Revenue Estimates
-
Earnings Preview: Clearside Biomedical, Inc. (CLSD) Q4 Earnings Expected to Decline
-
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Clearside Biomedical Inc (CLSD) Reports Q1 Loss, Tops Revenue Estimates
-
Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know
-
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Lags Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates
-
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Misses Revenue Estimates